1型与2型糖尿病的糖尿病周围神经病变存在差异:磁共振神经成像的见解
研究对120例糖尿病患者(1型35例、2型85例,其中伴糖尿病周围神经病变84例、不伴36例)行坐骨神经3T磁共振神经成像,并与临床、血清学和电生理数据相关分析。结果显示两型糖尿病周围神经病变的神经损伤类型不同:1型以T2w高信号病灶为主并与血糖控制差和神经传导丢失相关,2型以T2w低信号病灶为主并与脂代谢改变相关。
要点
- 1型糖尿病伴周围神经病变者T2w高信号病灶和HbA1c高于2型糖尿病伴周围神经病变者。
- 2型糖尿病伴周围神经病变者T2w低信号病灶和甘油三酯高于1型糖尿病伴周围神经病变者,HDL更低。
- T2w高信号病灶与胫神经复合肌肉动作电位、腓神经传导负相关,与神经病变残疾评分、症状评分正相关。
核心结论
- 糖尿病周围神经病变的主要神经损伤类型在1型和2型糖尿病之间存在差异。
- 1型糖尿病的主要神经病灶与血糖控制差和神经传导丢失相关,2型糖尿病的主要病灶与脂代谢改变相关。
- 作者认为这些发现可能有助于未来关于1型和2型糖尿病周围神经病变潜在病理生理通路和可能治疗的研究。
研究设计与样本
- 对120例糖尿病患者(1型糖尿病35例,2型糖尿病85例;伴糖尿病周围神经病变84例,不伴36例)行坐骨神经3T磁共振神经成像。
- 结果与患者的临床、血清学和电生理数据相关分析。
主要发现
- T2w高信号病灶与胫神经复合肌肉动作电位负相关(r=-0.58,p<0.0001),与腓神经传导正相关(r=0.51,p=0.0002),与神经病变残疾评分正相关(r=-0.54,p<0.0001),与神经病变症状评分正相关(r=0.52,p<0.0001),与HbA1c水平正相关(r=0.23,p=0.014)。
- T2w低信号病灶与神经病变残疾评分正相关(r=0.28,p=0.002),与神经病变症状评分正相关(r=0.36,p<0.0001),与血清甘油三酯正相关(r=0.34,p=0.0003),与血清高密度脂蛋白负相关(r=-0.48,p<0.0001)。
- 1型糖尿病伴糖尿病周围神经病变者与2型糖尿病伴糖尿病周围神经病变者相比,T2w高信号病灶升高(19.67±4.13% vs 12.49±1.23%,p=0.027),HbA1c升高(8.74±0.29% vs 7.11±0.16%,p<0.0001)。
- 2型糖尿病伴糖尿病周围神经病变者与1型糖尿病伴糖尿病周围神经病变者相比,T2w低信号病灶升高(23.41±2.69mm3 vs 11.43±1.74mm3,p=0.046),甘油三酯升高(220.70±23.70mg/dl vs 106.60±14.51mg/dl,p<0.0001),血清高密度脂蛋白降低(51.29±3.02mg/dl vs 70.79±4.65mg/dl,p<0.0001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To visualize and quantify differences of microstructural nerve damage in distal symmetric diabetic neuropathy (DPN) between type 1 diabetes (T1D) and type 2 diabetes (T2D), and to detect correlations between neuropathic symptoms and serological risk factors. METHODS: Three-tesla magnetic resonance neurography of the sciatic nerve was performed in 120 patients (T1D, n = 35; T2D, n = 85) with either DPN (n = 84) or no DPN (n = 36). Results were subsequently correlated with clinical, serological, and electrophysiological patient data. RESULTS: T2-weighted (T2w)-hyperintense lesions correlated negatively with tibial compound motor action potential (r = -0.58, p < 0.0001) and peroneal nerve conduction (r = 0.51, p = 0.0002), and positively with neuropathy disability score (NDS; r = -0.54, p < 0.0001), neuropathy symptom score (NSS; r = 0.52, p < 0.0001), and HbA1c level (r = 0.23, p = 0.014). T2w-hypointense lesions correlated positively with NDS (r = 0.28, p = 0.002), NSS (r = 0.36, p < 0.0001), and serum triglycerides (r = 0.34, p = 0.0003), and negatively with serum high-density lipoprotein (HDL; r = -0.48, p < 0.0001). For DPN in T1D, elevated values of T2w-hyperintense lesions (19.67 ± 4.13% vs 12.49 ± 1.23%, p = 0.027) and HbA1c (8.74 ± 0.29% vs 7.11 ± 0.16%, p < 0.0001) were found when compared to T2D. For DPN in T2D, elevated T2w-hypointense lesions (23.41 ± 2.69mm3 vs 11.43 ± 1.74mm3 , p = 0.046) and triglycerides (220.70 ± 23.70mg/dl vs 106.60 ± 14.51mg/dl, p < 0.0001), and lower serum HDL (51.29 ± 3.02mg/dl vs 70.79 ± 4.65mg/dl, p < 0.0001) were found when compared to T1D. INTERPRETATION: The predominant type of nerve lesion in DPN differs between T1D and T2D. Correlations found between lesion type and serological parameters indicate that predominant nerve lesions in T1D are associated with poor glycemic control and loss of nerve conduction, whereas predominant lesions in T2D are associated with changes in lipid metabolism. These findings may be helpful for future studies on the underlying pathophysiological pathways and possible treatments for DPN in T1D and T2D. Ann Neurol 2018;83:588-598.
引用
- Jende JME, Groener JB, Oikonomou D, et al. Diabetic neuropathy differs between type 1 and type 2 diabetes: Insights from magnetic resonance neurography. Ann Neurol. 2018. PMID: 29443416. doi:10.1002/ana.25182
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。